Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Oct 22;2(5):74-82.
doi: 10.5498/wjp.v2.i5.74.

Medication adherence in schizophrenia

Francisco Javier Acosta  1 , José Luis Hernández, José Pereira, Judit Herrera, Carlos J Rodríguez
Affiliations
Review

Medication adherence in schizophrenia

Francisco Javier Acosta et al. World J Psychiatry. .

Abstract

Non-adherence is a major problem in the treatment of schizophrenia. Its high prevalence, potentially severe consequences and associated costs make the study of this phenomenon a priority issue. In this article, basic non-adherence concepts of prevalence, consequences, evaluation methods, methodological restrictions of available studies, risk factors and intervention strategies, are reviewed. Studying non-adherence risk factors is a necessary step toward designing adequately oriented intervention strategies. An operative definition of adherence and good knowledge of its evaluation methods are essential to study this phenomenon. Unfortunately, most available studies contain methodological restrictions, especially concerning the evaluation methods, and an agreed operative definition of adherence has only very recently been reached. Knowing non-adherence risk factors, intervention strategies and available evidence on their effectiveness is essential in making treatment decisions in daily clinical practice.

Keywords: Adherence; Compliance; Non-adherence; Noncompliance; Schizophrenia.

PubMed Disclaimer

References

    1. Kane JM. Compliance issues in outpatient treatment. J Clin Psychopharmacol. 1985;5:22S–27S. - PubMed
    1. Kane JM. Treatment adherence and long-term outcomes. CNS Spectr. 2007;12:21–26. - PubMed
    1. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161:692–699. - PubMed
    1. Thieda P, Beard S, Richter A, Kane J. An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr Serv. 2003;54:508–516. - PubMed
    1. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull. 1995;21:419–429. - PubMed